Investor

BioMed

Last cheque observed Jun 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series CSeries BSeries D

Cheques on record
0%of best year0cheques in 12 months, 6 on record
Since the last cheque3066days00hrs00min00sec
Median round$39MRounds led0 of 6Mostly inUnited States, 50%
Pitch BioMed

BioMed highlights

  1. 01

    6 rounds on record

  2. 02

    Mostly Series C and Series B: 80% of its rounds

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first6 appearances

  1. 2018

    1 round

  2. Jun
    TriCaresSeries B · FR · Massdevice$26MWith 5 others
  3. 2017

    5 rounds

  4. Dec
    HookipaSeries C · AT · FinSMEs$60MWith 8 others
  5. Aug
    AmplyxSeries C · US · FinSMEs$67MWith 6 others
  6. Jul
    eFFECTOR TherapeuticsSeries C · US · FinSMEs$39MWith 10 others
  7. Jan
    MiracorSeries D · BE · Businesswire$30MWith 6 others
  8. Jan
    Aegea MedicalUS · FinSMEs$40MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Recently backed

The latest companies BioMed put money into.

Hookipa$60M · Dec 2017eFFECTOR Therapeutics$39M · Jul 2017

Quick answers about BioMed

What does BioMed invest in?

BioMed invests most often at Series C and Series B (80% of the rounds on record).

How active is BioMed?

6 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2018.

What has BioMed invested in recently?

Its most recent investments on record: TriCares (Series B, Jun 2018), Hookipa (Series C, Dec 2017) and Amplyx (Series C, Aug 2017).

How big are BioMed's cheques?

The median round it joins is $39M.

Does BioMed lead rounds?

Rarely, if at all: none of its 6 investments on record names it as the lead.

Where does BioMed invest?

Most of the companies it backs are in the United States (50%), France (17%) and Austria (17%).

Is BioMed investing now?

No investments in the last 12 months; the latest was in Jun 2018.

What kind of investor is BioMed?

BioMed is a growth equity firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it